Dirk Hose

13.6k citations

210 papers · 6.8k indexed · h-index 48

Impact in

Hematology top 0.1%
- Multiple Myeloma Research and Treatments
Oncology top 1%
- Peptidase Inhibition and Analysis

Papers in

Hematology 156
- Multiple Myeloma Research and Treatments 153
Genetics 23

Co-authors: Hartmut Goldschmidt Bernard Klein Jérôme Moreaux Thierry Rème Anja Seckinger John De Vos Anna Jauch Alboukadel Kassambara
Journals: Blood (62 papers)Haematologica (13 papers)Oncotarget (9 papers)Leukemia (6 papers)Clinical Cancer Research (5 papers)
Partner nations: Germany France United States

In The Last Decade

Dirk Hose

200 papers receiving 6.8k citations

Peers

Countries citing papers authored by Dirk Hose

Since Specialization

Citations

This map shows the geographic impact of Dirk Hose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Hose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Hose more than expected).

Fields of papers citing papers by Dirk Hose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Hose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Hose. The network helps show where Dirk Hose may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dirk Hose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dirk Hose Line = papers co-authored together Dirk Hose links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody Frontiers in Immunology ·Anja Seckinger, Vanessa Buatois, Valéry Moine, Bruno Daubeuf, Françoise Richard, Laurence Chatel, Noemí Cruz Rivera, Karla Anabel Lopez, Emeline Rousset, Krzysztof Masternak, Rita Mills, B.K. Mathur, Maximilian Dillis, Daniel Tiedemann, Yves Poitevin, Dirk Hose	2024	2
2	Resemblance-Ranking Peptide Library to Screen for Binders to Antibodies on a Peptidomic Scale International Journal of Molecular Sciences ·Ekkehard Henckel, Scuiiy SP, De Recondo, H. S. Villa, 尚武藤代, Roman S. Popov, Anja Seckinger, Dirk Hose, Alexander Nesterov‐Mueller	2022	5
3	Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis Journal of Experimental & Clinical Cancer Research ·J He, Gritten Rh, Philip Vlummens, Perry Haan, Anke Maes, Dirk Hose, Elke De Bruyne, Bart Ghesquière, Karin Vanderkerken, Kim De Veirman, Eline Menu	2022	26
4	MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma Blood Advances ·María Del Pilar Enríquez Gómez, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Herrojo Cristian, Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, Katja Weisel, Christof Scheid, Ulrich Keller, Dirk Hose, Florian Bassermann	2021	7
5	Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria Blood ·Christoph Kimmich, Tobias Terzer, Axel Benner, Tobias Dittrich, Kaya Veelken, Alexander Carpinteiro, Timon Hansen, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, Anna Jauch, Stefan Wörner, Jörg Beimler, Carsten Müller‐Tidow, Ute Hegenbart, Stefan Schönland	2020	61
6	Visfatin alters the cytokine and matrix-degrading enzyme profile during osteogenic and adipogenic MSC differentiation Osteoarthritis and Cartilage ·Hugh Skinner MacKenzie, J. Kent Werner, Marian Kampschulte, Klaus Frommer, Rika Fauziana, Larissa Fernanda Andrade Souza, Kristina Glenske, Dirk Hose, Thaqif El Khassawna, Jörn Pons‐Kühnemann, Stefan Rehart, Sabine Wenisch, Ulf Müller‐Ladner, Elena Neumann	2018	35
7	CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma—Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance Frontiers in Immunology ·Anja Seckinger, Jens Hillengaß, Martina Emde, Susanne Beck, Christoph Kimmich, Tobias Dittrich, Michael Hundemer, Anna Jauch, Ute Hegenbart, Marc‐Steffen Raab, Anthony D. Ho, Stefan Schönland, Dirk Hose	2018	32
8	Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion Cancer Immunology Research ·Kim De Veirman, Nathan De Beule, Ken Maes, Eline Menu, Elke De Bruyne, Hendrik De Raeve, Karel Fostier, Jérôme Moreaux, Alboukadel Kassambara, Dirk Hose, Roy Heusschen, Helena Eriksson, Karin Vanderkerken, Els Van Valckenborgh	2017	44
9	Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression Cancer Research ·Eva De Smedt, Ken Maes, Stefaan Verhulst, Hui Lui, Alboukadel Kassambara, Anke Maes, Nicolas Robert, Carlo Heirman, Andrew Cakana, Dirk Hose, Karine Breckpot, Leo A. van Grunsven, Kim De Veirman, Eline Menu, Karin Vanderkerken, Jérôme Moreaux, Elke De Bruyne	2017	30
10	Development of Gene Expression–Based Score to Predict Sensitivity of Multiple Myeloma Cells to DNA Methylation Inhibitors Molecular Cancer Therapeutics ·Jérôme Moreaux, Thierry Rème, G Maerschalk, Jean‐Luc Veyrune, Guilhem Requirand, Hartmut Goldschmidt, Dirk Hose, Bernard Klein	2012	39
11	Gene Expression Profiling in Multiple Myeloma—Reporting of Entities, Risk, and Targets in Clinical Routine Clinical Cancer Research ·Tobias Meißner, Anja Seckinger, Thierry Rème, Thomas Hielscher, Thomas Möhler, Kai Neben, Hartmut Goldschmidt, Bernard Klein, Dirk Hose	2011	30
12	Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma Haematologica ·M C Wang, Dirk Hose, Jérôme Moreaux, Brian A. Walker, Alexei Protopopov, Thierry Rème, Franck Pellestor, Véronique Pantesco, A. Jauch, Gareth J. Morgan, Hartmut Goldschmidt, Bernard Klein	2011	41
13	A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines Haematologica ·Jérôme Moreaux, Bernard Klein, Régis Bataille, Géraldine Descamps, Sophie Maïga, Dirk Hose, Richard Tingey, Anna Jauch, Thierry Rème, M Jourdan, Martine Amiot, Catherine Pellat‐Deceunynck	2010	124
14	Gene expression of anti‐ and pro‐apoptotic proteins in malignant and normal plasma cells British Journal of Haematology ·Michel Jourdan, Thierry Rème, Hartmut Goldschmidt, Geneviève Fiol, Véronique Pantesco, John De Vos, Jean‐François Rossi, Dirk Hose, Bernard Klein	2009	61
15	Gene Expression Profiling and Real-Time PCR Analyses Identify Novel Potential Cancer-Testis Antigens in Multiple Myeloma The Journal of Immunology ·Maud Condomines, Dirk Hose, Thierry Rème, Guilhem Requirand, Michael Hundemer, Matthieu Schoenhals, Hartmut Goldschmidt, Bernard Klein	2009	26
16	Embryonic stem cell markers expression in cancers Biochemical and Biophysical Research Communications ·Matthieu Schoenhals, Alboukadel Kassambara, John De Vos, Dirk Hose, Jérôme Moreaux, Bernard Klein	2009	207
17	[Reaming debris: a source of vital cells! First results of human specimens]. Der Unfallchirurg ·Katja Trinkaus, Sabine Wenisch, Luciana Freitas Constante, Dirk Hose, Reinhard Schnettler	2005	9
18	Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics Genes Chromosomes and Cancer ·Friedrich W. Cremer, Jelena Bila, saeed chehrazad, Mutlu Kartal‐Kaess, Dirk Hose, Carina Ittrich, Axel Benner, Marc S. Raab, L. E. Díaz, Marion Moos, Hartmut Goldschmidt, Claus R. Bartram, Anna Jauch	2005	74
19	High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH Cancer Genetics and Cytogenetics ·Friedrich W. Cremer, Mutlu Kartal‐Kaess, Dirk Hose, Jelena Bila, saeed chehrazad, Frauke Bellos, Marc S. Raab, مهدی زارع زردینی, Сушко Анна Вадимовна, 隆並木, Hartmut Goldschmidt, Marion Moos, Claus R. Bartram, Anna Jauch	2005	19
20	Bohrmehl: Eine Quelle vitaler Zellen!: Erste Ergebnisse von humanen Proben Der Unfallchirurg ·Katja Trinkaus, Sabine Wenisch, Luciana Freitas Constante, Dirk Hose, Reinhard Schnettler	2005	3

About Dirk Hose

Dirk Hose is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Immunology and Allergy, having authored 210 papers that have together received 6.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (153 papers), Protein Degradation and Inhibitors (49 papers), Peptidase Inhibition and Analysis (26 papers), Glycosylation and Glycoproteins Research (23 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (21 papers), Ubiquitin and proteasome pathways (19 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Immunotherapy and Immune Responses (16 papers). The work is most often cited by research in Hematology (3.5k citations), Oncology (2.1k citations), Genetics (784 citations), Molecular Biology (4.4k citations) and Immunology (1.2k citations). Dirk Hose has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Hartmut Goldschmidt, Bernard Klein, Jérôme Moreaux, Thierry Rème, Anja Seckinger, John De Vos, Anna Jauch, Alboukadel Kassambara, Anthony D. Ho and Jens Hillengaß. Their work appears in journals such as Blood, Haematologica, Oncotarget, Leukemia and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact